Caribou Biosciences (CRBU) Change in Acquisitions & Divestments (2022 - 2026)

Caribou Biosciences (CRBU) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $46.1 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 30.04% year-over-year to $46.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $233.0 million (down 36.4% YoY) and the FY2025 annual result came in at $252.8 million, down 36.39% from the prior year.
• Change in Acquisitions & Divestments fell to $46.1 million in Q1 2026 per CRBU's latest filing, from $61.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $120.7 million in Q3 2024 and bottomed at $39.3 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $68.4 million (2025), against an average of $75.7 million.
• The widest annual swing landed in 2023, when Change in Acquisitions & Divestments surged 151.06%; it then tumbled 47.43% in 2025.
• Tracing CRBU's Change in Acquisitions & Divestments over 5 years: stood at $89.7 million in 2022, then sank by 38.72% to $55.0 million in 2023, then soared by 30.81% to $71.9 million in 2024, then retreated by 14.11% to $61.8 million in 2025, then decreased by 25.32% to $46.1 million in 2026.
• Per Business Quant, the three latest CRBU Change in Acquisitions & Divestments figures stand at $46.1 million (Q1 2026), $61.8 million (Q4 2025), and $68.4 million (Q3 2025).

Peer Comparison